Evidence map›Paper›PMID 41897453›Full record

ArticleAntioxidants (Basel, Switzerland)2026

Effects of Melatonin and

Alba González-Robles, Beatriz San Miguel, Sara Román-Sagüillo, María Juárez-Fernández, José L Mauriz, Susana Martínez-Flórez, Esther Nistal, María Victoria García-Mediavilla, Sonia Sánchez-Campos

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Biomedicines · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alba González-RoblesInstituto Universitario de Biomedicina (IBIOMED), Universidad de León, 24007 León, Spain.ORCID 0009-0001-9640-0863
Beatriz San MiguelInstituto Universitario de Biomedicina (IBIOMED), Universidad de León, 24007 León, Spain.ORCID 0000-0002-4890-6309
Sara Román-SagüilloInstituto Universitario de Biomedicina (IBIOMED), Universidad de León, 24007 León, Spain.ORCID 0000-0002-4200-7919
María Juárez-FernándezInstituto Universitario de Biomedicina (IBIOMED), Universidad de León, 24007 León, Spain.ORCID 0000-0003-4678-3058
José L MaurizInstituto Universitario de Biomedicina (IBIOMED), Universidad de León, 24007 León, Spain.ORCID 0000-0003-3160-8599
Susana Martínez-FlórezInstituto Universitario de Biomedicina (IBIOMED), Universidad de León, 24007 León, Spain.
Esther NistalInstituto Universitario de Biomedicina (IBIOMED), Universidad de León, 24007 León, Spain.ORCID 0000-0002-2201-5575
María Victoria García-MediavillaInstituto Universitario de Biomedicina (IBIOMED), Universidad de León, 24007 León, Spain.ORCID 0000-0002-5722-7500
Sonia Sánchez-CamposInstituto Universitario de Biomedicina (IBIOMED), Universidad de León, 24007 León, Spain.ORCID 0000-0003-2672-734X

Funding

Fellowship from Ministerio de Educación FPU18/06257Fellowship from Ministerio de Educación FPU22/02734Instituto de Salud Carlos III (ISCIII) co-funded by the European Union. CIBERehd is funded by the ISCIII PI20/00690Junta de Castilla y León and the European Regional Development Fund GRS2126/A/2020Junta de Castilla y León and the European Regional Development Fund LE017-P20Ministerio de Ciencia, Innovación y Universidades PID2020- 120363RB-I00
6 · The paper itself

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common cause of chronic liver disease worldwide. Fibrosis is the main prognostic factor and the last reversible stage before cirrhosis, yet therapeutic options remain limited. Given the strong contribution of gut dysbiosis to MASLD progression, strategies targeting the gut microbiota are of growing interest. This study aims to evaluate the effect of melatonin, a well-known antioxidant, anti-inflammatory and antifibrotic compound, and

Indexed as

Akkermansia muciniphilagut microbiotaliver fibrosisMASLDmelatonin

Identifiers

PMID41897453
PMCPMC13023461

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.